Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbal cream versus podophyllin, imiquimod, cryotherapy, and placebo for external genital warts
IRCT20250916067270N1Phase 2Recruiting
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2025
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of podophyllin and imiquimod in anogenital warts (10 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Number of genital wart lesions, Disappearance of lesions and 1 more. Started Dec 2025; status: recruiting.
02
Drugs
podophyllinimiquimod
03
Conditions
anogenital warts
Beyond the preview
Go deeper on IRCT20250916067270N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250916067270N1.